Comparable Immune Function Inhibition by the Infliximab Biosimilar CT-P13: Implications for Treatment of Inflammatory Bowel Disease-Reference-Cited by-同舟云学术

Comparable Immune Function Inhibition by the Infliximab Biosimilar CT-P13: Implications for Treatment of Inflammatory Bowel Disease

Published:2016-10-08 Issue: Volume: Page:jjw183
ISSN:1873-9946
Container-title:Journal of Crohn's and Colitis
language:en
Short-container-title:ECCOJC

Author:

Lim Ki Jung,Lee So Jung,Kim Sunghwan,Lee Su Yeon,Lee Min Seob,Park Yoon A.,Choi Eun Jin,Lee Eun Beom,Jun Hwang Keun,Cho Jong Moon,Lee SooYoung,Kwon Ki Sung,Lim Byung Pil,Jeon Myung-Shin,Shin Eui Cheol,Choi Yong Sung,Fudim Ella,Picard Orit,Yavzori Miri,Ben-Horin Shomron,Chang Shin Jae

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Link

http://academic.oup.com/ecco-jcc/article-pdf/11/5/593/13946424/jjw183.pdf

Reference60 articles.

1. Tumor Necrosis Factor (TNF)

2. Critical involvement of transmembrane tumor necrosis factor-alpha in endothelial programmed cell death mediated by ionising radiation and bacterial endotoxin;Eissner;Blood,1995

3. Anti-tumor necrosis factor modulates anti-CD3-triggered T cell cytokine gene expression in vivo.

4. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells

5. Cytokines and autoimmunity

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic use of specific tumour necrosis factor inhibitors in inflammatory diseases including COVID-19;Biomedicine & Pharmacotherapy;2021-08

2. Reporting of quality attributes in scientific publications presenting biosimilarity assessments of (intended) biosimilars: a systematic literature review;European Journal of Pharmaceutical Sciences;2020-11

3. Propagation of EBV-driven Lymphomatous Transformation of Peripheral Blood B Cells by Immunomodulators and Biologics Used in the Treatment of Inflammatory Bowel Disease;Inflammatory Bowel Diseases;2020-04-23

4. TNF-Alpha Blockers in Inflammatory Bowel Diseases: Practical Recommendations and a User’s Guide: An Update;Digestion;2020

5. Multimeric antibodies with increased valency surpassing functional affinity and potency thresholds using novel formats;mAbs;2020-01-01